Pediatric Endocrinology Diabetes and Metabolism

Metabolic outcomes and insulin therapy modifications during Ramadan fasting in children with type 1 diabetes mellitus in low-resource settings

  1. Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

  2. Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

  3. Department of Child Health, Airlangga General Academic Hospital, Surabaya, Indonesia

  4. Division of Pediatric Endocrinology, Department of Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  5. Department of Pediatrics and Genetics, Al-Makassed Hospital and Al-Quds Medical School, East Jerusalem, Palestine

Pediatr Endocrinol Diabetes Metab 2026; 32:

Data publikacji online: 2026/07/30
Article file
0444_Metabolic outcomes.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Hassanein M, Al-Arouj M, Hamdy O, et al. Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Pract 2017; 126: 303–316. doi: 10.1016/j.diabres.2017.03.003.
  2. Ibrahim M, Davies MJ, Ahmad E, et al. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Res Care 2020; 8: e001248. doi: 10.1136/bmjdrc-2020-001248.
  3. Deeb A, Al Qahtani N, Akle M, et al. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract 2017; 126: 10–15. doi: 10.1016/j.diabres.2017.01.015.
  4. Abusahmin H, Abdelgadir E, Eledrisi MS, et al. Diabetes and Ramadan fasting (2023): the year in review. J Diabetes Endocr Pract 2024; 07: 53–65.
  5. Semerci Çakmak V, Sönmez Sari E, Çetinkaya Özdemir S. Experiences of adults with type 2 diabetes mellitus with low socioeconomic status: a qualitative study. BMC Public Health 2025; 25: 381. doi: 10.1186/s12889-025-21582-1.
  6. Lessan N, Saadane I, Alkaf B, et al. The effects of Ramadan fasting on activity and energy expenditure. Am J Clin Nutr 2018; 107: 54–61. doi: 10.1093/ajcn/nqx016.
  7. Alguwaihes AM, Alyusuf EY, Alrajeh A, et al. Altered Ramadan fasting glycemic profiles of adults with type 1 diabetes reveal strong evidence of underestimated insulin adjustments: a 3-year observational study in Arab settings. Front Endocrinol (Lausanne) 2025; 16: 1399990. doi: 10.3389/fendo.2025.1399990.
  8. Afandi B, Kaplan W, Al Hassani N, et al. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with type 1 diabetes. J Endocrinol Invest 2017; 40: 741–744. doi: 10.1007/s40618-017-0633-y.
  9. Beshyah SA, Hafidh K, Abusahmin H. Diabetes and Ramadan fasting (2024): a thematic overview. J Diabetes Endocr Pract 2025; 8: 157–165.
  10. Wannes S, Al Qusayer D, El Abed S, Ben Fredj M. Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system. Acta Diabetol 2023; 60: 851–855. doi: 10.1007/s00592-023-02049-4.
  11. Elbarbary NS, Rahman Ismail EA. Time in tight glucose range in adolescents and young adults with diabetes during Ramadan intermittent fasting: Data from real-world users on different treatment strategies. Diabetes Res Clin Pract 2025; 221: 112042. doi: 10.1016/j.diabres.2025.112042.
  12. Virmani A, Brink SJ, Middlehurst A, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Management of the child, adolescent, and young adult with diabetes in limited resource settings. Pediatr Diabetes 2022; 23: 1529–1551. doi: 10.1111/pedi.13456.
  13. Foulds A, Josey C, Kehlenbrink S, et al. Human versus analogue insulin for youth with type 1 diabetes in low-resource settings (HumAn-1): protocol for a randomised controlled trial. BMJ Open 2025; 15: e092432. doi: 10.1136/bmjopen-2024-092432.
  14. Silver B, Ramaiya K, Andrew SB, et al. EADSG Guidelines: insulin therapy in diabetes. Diabetes Ther 2018; 9: 449–492. doi: 10.1007/s13300-018-0384-6.
  15. Ahmed S, Khokhar N, Shubrook JH. Fasting during Ramadan: a comprehensive review for primary care providers. Diabetology 2022; 3: 276–291. doi: 10.3390/diabetology3020019.
  16. Rashid F, Abdelgadir E, Bashier A. A systematic review on the safety of Ramadan fasting in high-risk patients with diabetes. Diabetes Res Clin Pract 2020; 164: 108161. doi: 10.1016/j.diabres.2020.108161.
  17. Alabbood MH, Ho KW, Simons MR. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: a literature review. Diabetes Metab Syndr Clin Res Rev 2017; 11: 83–87. doi: 10.1016/j.dsx.2016.06.028.
  18. Beshyah SA, Ali KF, Hafidh K, Hajjaji IM. Ramadan fasting and diabetes 2019: the year in review. Diabetes Res Clin Pract 2021; 172: 108593. doi: 10.1016/j.diabres.2020.108593.
  19. Uddin KN. Diabetes and fasting in Ramadan. J Med 2024; 25: 103–106. doi: 10.3329/jom.v25i2.74664.
  20. Muammar T, Fojas EGF, Helal R, Lessan N. Ramadan fasting among older children and adolescents with type 1 diabetes mellitus: a real-world study from the UAE. Front Nutr 2022; 9: 786678. doi: 10.3389/fnut.2022.786678.
  21. Arueyingho O, O›Kane AA, Marshall P, et al. Designing Okuma: A digital health tool for type 2 diabetes in Nigeria. In: AfriCHI ‹25: Proceedings of the 5th Biennial African Human Computer Interaction Conference; 2025 Nov 4–8; Cairo, Egypt. New York (NY): Association for Computing Machinery; 2025. p. 1–22. doi: 10.1145/3757232.3757233.
  22. Alanzi TM, Arif W, Alotaibi A, et al. Impact of ChatGPT on diabetes mellitus self-management among patients in Saudi Arabia. Cureus 2025; 17: e81855. doi: 10.7759/cureus.81855.
  23. Khalid S, Ramzan S, Iqbal MM, et al. Tab transformer with meta-ensemble learning approaches for enhanced diabetes prediction. PeerJ Comput Sci. 2025; 11: e3206. doi: 10.7717/peerj-cs.3206.
  24. Salti I, Bénard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27: 2306–2311. doi: 10.2337/diacare.27.10.2306.
  25. Lessan N, Hannoun Z, Hasan H, Barakat MT. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab 2015; 41: 28–36. doi: 10.1016/j.diabet.2014.11.004.
  26. Elhoseeny MM, Rageh F, Bakry N, et al. Culturally adapted hypocaloric diet improves hepatic steatosis, inflammatory and oxidative biomarkers in Egyptian MASLD patients: a single-arm interventional study. Lipids Heal Dis 2025; 24: 286. doi: 10.1186/s12944-025-02710-7.
  27. Yunir E, Nugraha ARA, Rosana M, et al. Risk factors of severe hypoglycemia among patients with type 2 diabetes mellitus in outpatient clinic of tertiary hospital in Indonesia. Sci Rep 2023; 13: 16259. doi: 10.1038/s41598-023-43459-2.
  28. Ahmed SH, Chowdhury TA, Hussain S, et al. Ramadan and diabetes: a narrative review and practice update. Diabetes Ther 2020; 11: 2477–2520. doi: 10.1007/s13300-020-00886-y.
  29. Saadane I, Ali T, El-Laboudi A, Lessan N. Ramadan fasting in insulin-treated patients is associated with potentially unfavourable changes in glucose metrics: a flash glucose monitoring (FGM) study. Diabetes Res Clin Pract 2021; 172: 108592. doi: 10.1016/j.diabres.2020.108592.
  30. Zainudin SB, Abu Bakar KNB, Abdullah SB, Hussain AB. Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan. Ther Adv Endocrinol Metab 2018; 9: 231–240. doi: 10.1177/2042018818781669.

Share
without publication fees